Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 1, 2007

Argenta Adds New Target to Genentech Collaboration

  • Argenta Discovery added a second two-year drug discovery project to its deal with Genentech. Scientists from the two companies will exploit Argenta’s expertise in computer-aided drug design, medicinal chemistry, and biology to discover new chemical entities acting against a second undisclosed drug target defined by Genentech.

    The agreement provides options to further expand the relationship, including opportunities to pursue additional discovery projects.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »